郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Effects of dose and route on the disposition and kinetics of 1-butyl-1-methylpyrrolidinium chloride in male F-344 rats.

期刊:Drug metabolism and disposition: the biological fate of chemicals发表年份:2009作者:G A Knudsen; Y Cheng; R K Kuester; M J Hooth; I G Sipes

药效评价Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors.

期刊:Molecular pharmacology发表年份:2009作者:Guillaume Lebon; Christopher J Langmead; Ben G Tehan; Edward C Hulme

药效评价Distinct modes of molecular regulation of CCL3 induced calcium flux in monocytic cells.

期刊:Biochemical pharmacology发表年份:2009作者:Clara Moyano Cardaba; Anja Mueller

药效评价Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2(High) receptor.

期刊:Synapse (New York, N.Y.)发表年份:2009作者:Philip Seeman; Hong-Chang Guan